These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 12679522)

  • 21. Patched1 inhibits epidermal progenitor cell expansion and basal cell carcinoma formation by limiting Igfbp2 activity.
    Villani RM; Adolphe C; Palmer J; Waters MJ; Wainwright BJ
    Cancer Prev Res (Phila); 2010 Oct; 3(10):1222-34. PubMed ID: 20858761
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Hedgehog pathway and its inhibitors: Emerging therapeutic approaches for basal cell carcinoma.
    Jain R; Dubey SK; Singhvi G
    Drug Discov Today; 2022 Apr; 27(4):1176-1183. PubMed ID: 34896624
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Crosstalk between Desmoglein 2 and Patched 1 accelerates chemical-induced skin tumorigenesis.
    Brennan-Crispi DM; Hossain C; Sahu J; Brady M; Riobo NA; Mahoney MG
    Oncotarget; 2015 Apr; 6(11):8593-605. PubMed ID: 25871385
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Targeting the hedgehog pathway to treat basal cell carcinoma.
    Geeraert P; Williams JS; Brownell I
    J Drugs Dermatol; 2013 May; 12(5):519-23. PubMed ID: 23652945
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Zfx facilitates tumorigenesis caused by activation of the Hedgehog pathway.
    Palmer CJ; Galan-Caridad JM; Weisberg SP; Lei L; Esquilin JM; Croft GF; Wainwright B; Canoll P; Owens DM; Reizis B
    Cancer Res; 2014 Oct; 74(20):5914-24. PubMed ID: 25164012
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Basal cell carcinomas in mice overexpressing sonic hedgehog.
    Oro AE; Higgins KM; Hu Z; Bonifas JM; Epstein EH; Scott MP
    Science; 1997 May; 276(5313):817-21. PubMed ID: 9115210
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression of sonic hedgehog signal transducers, patched and smoothened, in human basal cell carcinoma.
    Tojo M; Mori T; Kiyosawa H; Honma Y; Tanno Y; Kanazawa KY; Yokoya S; Kaneko F; Wanaka A
    Pathol Int; 1999 Aug; 49(8):687-94. PubMed ID: 10504535
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The role of hedgehog signalling in tumorigenesis.
    Wicking C; McGlinn E
    Cancer Lett; 2001 Nov; 173(1):1-7. PubMed ID: 11578802
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Basal cell carcinomas: attack of the hedgehog.
    Epstein EH
    Nat Rev Cancer; 2008 Oct; 8(10):743-54. PubMed ID: 18813320
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical implications of hedgehog signaling pathway inhibitors.
    Liu H; Gu D; Xie J
    Chin J Cancer; 2011 Jan; 30(1):13-26. PubMed ID: 21192841
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Novel Approaches in Non-Melanoma Skin Cancers-A Focus on Hedgehog Pathway in Basal Cell Carcinoma (BCC).
    Chmiel P; Kłosińska M; Forma A; Pelc Z; Gęca K; Skórzewska M
    Cells; 2022 Oct; 11(20):. PubMed ID: 36291078
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression profile of sonic hedgehog signaling-related molecules in basal cell carcinoma.
    Kim HS; Kim YS; Lee C; Shin MS; Kim JW; Jang BG
    PLoS One; 2019; 14(11):e0225511. PubMed ID: 31756206
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Activation of the transcription factor Gli1 and the Sonic hedgehog signalling pathway in skin tumours.
    Dahmane N; Lee J; Robins P; Heller P; Ruiz i Altaba A
    Nature; 1997 Oct; 389(6653):876-81. PubMed ID: 9349822
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Cutaneous epithelial tumors. Molecular biology and pathogenesis-based therapy].
    Reifenberger J; Schön MP
    Hautarzt; 2003 Dec; 54(12):1164-70. PubMed ID: 14634745
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy of Hedgehog pathway inhibitors in Basal cell carcinoma.
    Basset-Seguin N; Sharpe HJ; de Sauvage FJ
    Mol Cancer Ther; 2015 Mar; 14(3):633-41. PubMed ID: 25585509
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MTOR promotes basal cell carcinoma growth through atypical PKC.
    Chow RY; Levee TM; Kaur G; Cedeno DP; Doan LT; Atwood SX
    Exp Dermatol; 2021 Mar; 30(3):358-366. PubMed ID: 33617094
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tumor Architecture and Notch Signaling Modulate Drug Response in Basal Cell Carcinoma.
    Eberl M; Mangelberger D; Swanson JB; Verhaegen ME; Harms PW; Frohm ML; Dlugosz AA; Wong SY
    Cancer Cell; 2018 Feb; 33(2):229-243.e4. PubMed ID: 29395868
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sustained Hedgehog signaling is required for basal cell carcinoma proliferation and survival: conditional skin tumorigenesis recapitulates the hair growth cycle.
    Hutchin ME; Kariapper MS; Grachtchouk M; Wang A; Wei L; Cummings D; Liu J; Michael LE; Glick A; Dlugosz AA
    Genes Dev; 2005 Jan; 19(2):214-23. PubMed ID: 15625189
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Small Molecule Inhibitors of the Hedgehog Pathway in the Treatment of Basal Cell Carcinoma of the Skin.
    Danhof R; Lewis K; Brown M
    Am J Clin Dermatol; 2018 Apr; 19(2):195-207. PubMed ID: 28887802
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hedgehog signaling pathway as a therapeutic target in breast cancer.
    Katano M
    Cancer Lett; 2005 Sep; 227(2):99-104. PubMed ID: 16112412
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.